Clinical Trial

Clinical Validation of Vital-PICASO for Predicting Cardiac Arrest Within 24 Hours

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this retrospective study is to evaluate the clinical performance of Vital-PICASO, an artificial intelligence-based biological signal analysis software designed to predict the risk of in-hospital cardiac arrest within 24 hours using vital-sign data collected from adult general ward inpatients. Electronic medical record data from patients aged 19 years or older who were admitted to a general ward at Seoul National University Hospital will be retrospectively reviewed. Vital-sign variables include systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, body temperature, and, when available, oxygen saturation. Eligible data will be classified as cardiac arrest-positive or cardiac arrest-negative according to predefined reference-standard criteria. The blinded datasets will then be analyzed using Vital-PICASO, and the software-generated risk scores will be compared with the reference-standard classifications. Predictive performance will be evaluated separately using models that include oxygen saturation and models that do not include oxygen saturation.
Trial Details
NCT Number NCT07742943
Lead Sponsor Huinno AIM
Conditions Heart Arrest
Enrollment 387 participants
Start Date 2025-08-20
Primary Completion 2025-12-19 (estimated)
Study Completion 2025-12-19 (estimated)
Updated on ClinicalTrials.gov 2026-08-03